Cambridge Investment Research Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,083
Closed -$1.05M 3349
2023
Q3
$1.05M Sell
9,083
-714
-7% -$82.6K ﹤0.01% 1542
2023
Q2
$1.01M Sell
9,797
-3,609
-27% -$371K ﹤0.01% 1609
2023
Q1
$1.46M Sell
13,406
-1,251
-9% -$137K 0.01% 1330
2022
Q4
$1.67M Sell
14,657
-1,571
-10% -$179K 0.01% 1183
2022
Q3
$1M Buy
16,228
+1,804
+13% +$112K 0.01% 1477
2022
Q2
$1.15M Sell
14,424
-1,213
-8% -$96.7K 0.01% 1375
2022
Q1
$1.65M Sell
15,637
-3,741
-19% -$394K 0.01% 1258
2021
Q4
$2.09M Buy
19,378
+924
+5% +$99.6K 0.01% 1121
2021
Q3
$2.02M Sell
18,454
-2,298
-11% -$252K 0.01% 1092
2021
Q2
$1.94M Buy
+20,752
New +$1.94M 0.01% 1141
2021
Q1
Sell
-8,605
Closed -$629K 3035
2020
Q4
$629K Buy
8,605
+3,234
+60% +$236K ﹤0.01% 1614
2020
Q3
$417K Buy
+5,371
New +$417K ﹤0.01% 1724
2020
Q2
Sell
-10,463
Closed -$310K 2550
2020
Q1
$310K Buy
+10,463
New +$310K ﹤0.01% 1663